ALFA FinderBSE filing, BSE: 524548. Summary written from the filing by ALFA Finder's alert engine.
Sharma East India Hospitals & Medical Research Ltd: key numbers
- Share price
- ₹80.23
- Market cap
- ₹26.35 Cr
- Revenue (annual)
- ₹35.93 Cr
- Net profit (annual)
- ₹1.24 Cr
- P/E (TTM)
- 23.3×Sector 54.5×
- Promoter holding
- 53.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharma East India Hospitals & Medical Research Ltd
All →Sharma East India Hospitals & Medical Research Q2 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.4 Cr (+10.6% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY
Sharma East India Hospitals & Medical Research Board Meeting Date
Sharma East India Hospitals informs BSE of a Board meeting on 7 Nov 2026. The agenda proposes approval of unaudited Q1 and H1 2026-27 results.
Sharma East India Hospitals & Medical Research Other Announcement
Sharma East India Hospitals filed a Reg 74(5) SEBI (DP) dematerialization certificate for Q2 FY27. It is a routine RTA compliance confirmation with no new business content.
Sharma East India Hospitals & Medical Research Annual General Meeting
Sharma East India Hospitals & Medical Research Ltd. conducted its 37th Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary business resolutions.
Sharma East India Hospitals & Medical Research Annual Report
Sharma East India Hospitals has filed its 37th Annual Report for FY 2025-2026. The report includes details concerning the upcoming Annual General Meeting.
Sharma East India Hospitals & Medical Research Annual General Meeting
The company approved its Annual Report and scheduled the 37th Annual General Meeting for September 30, 2026. Various AGM-related procedural dates were also finalized.
Other board meeting outcome announcements
All →Shri Keshav Cements & Infra Board Meeting Outcome
Shri Keshav Cements' board approved un-audited financial and segment-wise revenue results for the quarter and half-year ended 30 September 2026. No other material decisions were transacted.
Balmer Lawrie Investments Board Meeting Outcome
Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.
- Execution
- FY 2026-27
Jiwanram Sheoduttrai Industries Board Meeting Outcome
Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.
Finolex Cables Board Meeting Outcome
Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).
Chatterbox Technologies Board Meeting Outcome
Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.
BCC Fuba India Board Meeting Outcome
BCC Fuba India's board met on November 6, 2026 and took note of consolidated related party transactions for the half year ended September 30, 2026. No financial results, capital raise or other material decision was reported.